Hyde, J F <br/><br/>
Vasoactive intestinal polypeptide mRNA and peptide levels are decreased in the anterior pituitary of the human growth hormone-releasing hormone transgenic mouse.  [electronic resource] 

 -  Journal of neuroendocrinology  Jan 1996 
 - 9-15 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0953-8194 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2826.1996.tb00681.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cerebral Cortex--metabolism<br/>Estradiol--pharmacology<br/>Growth Hormone--blood<br/>Growth Hormone-Releasing Hormone--genetics<br/>Humans<br/>Hypothalamo-Hypophyseal System--drug effects<br/>Hypothalamus--metabolism<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Pituitary Gland, Anterior--cytology<br/>Prolactin--blood<br/>RNA, Messenger--genetics<br/>Vasoactive Intestinal Peptide--metabolism